stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) EBITDA
Stevanato Group S.p.A.'s EBITDA for fiscal 2025 was $325.1M, up 24.3% from $261.6M in fiscal 2024. Over the twelve months to 30 September 2026 it was $351.1M. Over the past ten years it has ranged from $112.0M (fiscal 2019) to $325.1M (fiscal 2025) — the current reading is the highest in ten years. Stevanato Group S.p.A. ranks 17th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $325.1M | 24.26% |
| FY2024 | $261.6M | (13.41%) |
| FY2023 | $302.2M | 11.49% |
| FY2022 | $271.0M | 4.80% |
| FY2021 | $258.6M | 44.02% |
| FY2020 | $179.6M | 60.34% |
| FY2019 | $112.0M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $98.3M | 34.08% |
| Jun 2026 | $73.3M | (1.15%) |
| Mar 2026 | $74.2M | (29.53%) |
| Dec 2025 | $105.3M | 18.96% |
| 22 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| NVST Envista Holdings Corporation compare | $428.9M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| STVN Stevanato Group S.p.A. | $351.1M |
| ICUI ICU Medical, Inc. compare | $314.2M |
| TFX Teleflex Incorporated compare | $256.2M |
| WRBY Warby Parker Inc. compare | $59.0M |
| ATRC AtriCure, Inc. compare | $34.2M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
| PLSE Pulse Biosciences, Inc compare | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on STVN
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement